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Objective: To assess serum levels of  25-hydroxyvitamin D [25(OH)D] in the first trimester and to determine the factors 
affecting deficiency levels and its association with pregnancy outcomes.
Methods: Serum 25(OH)D concentrations were measured at 11-14 weeks’ gestation in 229 singleton pregnancies using 
liquid chromatography-tandem mass spectrometry.   
Results: The median serum 25(OH)D concentration was 10.8 ng/mL and 45.9% of  women had severe vitamin D deficien-
cy with concentrations of   <10 ng/mL.  Logistic regression analysis revealed that covered dressing style, lack of  multivitamin 
intake, season of  blood sampling (November-April) were factors associated with 25(OH)D deficiency. There was a negative 
correlation between 25(OH)D levels and gestational age at sampling. Low 25(OH)D levels were not associated with adverse 
pregnancy outcomes. Higher rate of  cesarean section (CS) was noted in women with 25(OH)D ≥10 ng/mL compared to 
those with 25(OH)D < 10mg/ml ( p= 0.01). 
Conclusion: A high prevalence of  vitamin D deficiency was observed in early pregnancy which was related to dress code, 
use of  multi-vitamins and season at sampling. Low 25(OH)D levels were not  related with adverse pregnancy outcomes. 
Women with severe vitamin D deficiency were more likely to deliver vaginally.
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Introduction
The prevalence of  vitamin D deficiency has increased 
and continues to be a major public health problem in 
many countries1. High prevalence of  vitamin D defi-
ciency has been observed among pregnant women even 
in sun-rich areas2. The main source of  vitamin D is en-
dogenous synthesis in the skin following exposure to 
sunlight, though a small percentage comes from dietary 
sources and supplement intake3. Vitamin D level is in-
fluenced by many factors such as skin pigmentation, use 
of  sunscreen, ethnicity, dress code,, geographic latitude, 
seasonal variation and use of  prenatal vitamins4,5,6,7.
Several studies reported the relationship between ma-
ternal vitamin D deficiency and adverse maternal and 
fetal outcomes including gestational diabetes, preec-
lampsia, preterm labor, low birth weight, and ceasarean 
section8,9.
Determination of  vitamin D status in the first trimester 
provides an opportunity for early detection and proph-
ylaxis of  vitamin D deficiency that may help to reduce 
adverse pregnancy outcomes. The aim of  this study was 
to assess the first trimester serum levels of  25-hydrox-
yvitamin D [25(OH)D] and the factors affecting the 
low levels in pregnant women. The association between 
vitamin D status and obstetric-neonatal outcomes were 
also evaluated.
Materials and methods
A total of  229 consecutive pregnant women who attend-
ed for their first antenatal visit (11-14 weeks of  preg-
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nancy) at the outpatient clinic of  Obstetrics and Gy-
necology, Bezmialem Vakif  University, Istanbul, Turkey 
between December 2012 and July 2014 were studied. 
This study was approved by the Ethics Committee of  
our hospital. All participants were informed about the 
purpose of  the study and requested to participate after 
giving written consent. They were asked to complete a 
questionnaire that included the characteristics of  their 
pregnancy and information about the factors associated 
with vitamin D status. Non-fasting blood samples were 
taken and analyzed for 25(OH)D levels. The pregnan-
cies were followed up until the end of  their last trimes-
ter and the pregnancy outcomes were recorded in our 
database. At the end of  the study, the data of  pregnancy 
and neonatal outcomes were obtained from medical re-
cords and reviewed cautiously.
Women with a history of  thyroid, parathyroid or ad-
renal disease, hepatic or renal failure, metabolic bone 
diseases and those taking medications that might affect 
vitamin D metabolism were excluded from the study. 
Multiple pregnancies were also excluded. None of  the 
women in this study had previously received vitamin D 
supplementation.
Data on maternal characteristics included age, parity, 
blood pressure, pre-pregnancy weight, height, date of  
last menstrual period, smoking status (yes or no), ed-
ucation level, gestational age at blood sampling, type 
of  clothing, consumption of  milk and dairy products, 
use of  multivitamin supplements, sunlight exposure 
(between 10 AM and 3 PM) and season of  blood col-
lection. Covered dressing style was defined as wearing 
dresses which cover body completely excluding hands 
and face whereas uncovered dressing style was wearing 
dresses exposing body to more sun light in a permissive 
manner. Consuming dairy products of  at least 200 mL 
of  milk or other milkproducts including cheese, but-
ter, yoghurt 4-7 days/week was regarded as ‘sufficient’ 
milk consumption, whereas intake of  dairy products 
three times a week or less was defined as ‘insufficient’ 
consumption10. The season for blood collection was di-
chotomized into winter (November-April) and summer 
(May-October).
Obstetric and neonatal data including gestational age, 
mode of  delivery, and frequency of  pregnancy-relat-
ed complications, birth weight, Apgar scores, neonatal 
gender and presence of  congenital anomalies were also 
recorded. The gestational age at delivery was deter-
mined by menstrual dating, while the ultrasound esti-
mates of  gestational age were used in women that had 
missed or uncertain dates. The estimated date of  deliv-
ery was determined by last menstrual period or by early 
ultrasound. Gestational hypertension was defined as a 
blood pressure of  140/90 mmHg or higher that devel-
ops after 20 weeks of  gestation. Proteinuria was defined 
as a urine dipstick test ≥2+, or more than 300 mg of  
protein in a 24-hour urine collection. Pre-eclampsia was 
defined as gestational hypertension with proteinuria11. 
The diagnosis of  gestational diabetes mellitus (GDM) 
was performed using a 2-step approach which involves 
an initial screening by measuring the plasma glucose 1 
hour after a 50-g oral glucose load. If  the plasma glu-
cose level was 135 mg/dL or higher, it was followed 
by a 3-hour 100-g oral glucose tolerance test to estab-
lish the diagnosis of  GDM12. We defined preterm de-
livery as live births between 21 weeks and 36 weeks 6 
days of  gestation13. Stillbirth was defined as fetal death 
occurring after 20 weeks of  gestation14. Infants were 
considered to be small-for gestational age (SGA) if  the 
birth weight was less than the 10 th percentile for their 
gestational age15.
Measurement of  25(OH)D3 and 25(OH)D2 in human 
serum was made by using liquid chromatography-tan-
dem mass spectrometry (LC-MS/MS) with an Agilent 
1200 Infinity liquid chromatography (Agilent Technolo-
gies) coupled to an Agilent Technologies 6460 LC-MS/
MS. The summation of  serum 25(OH)D2 and 25(OH)
D3 was used to reflect total serum 25(OH)D concen-
trations. The inter-assay and intra-assay coefficients of  
variation of  total serum 25(OH)D level were 6.84% 
and 2.21%, respectively. The lower and upper limits 
of  detection were 4.0 and 200 ng/mL, respectively. 
Although there is no consensus regarding the optimal 
25(OH)D level, vitamin D status was categorized into 
groups as serum 25(OH)D levels <10 ng/mL, between 
10–19 ng/mL, 20–29 ng/mL and >30 ng/mL, indicat-
ing severe, moderate and mild vitamin D deficiency and 
desirable reference limit, respectively16.
Data was presented as mean ± standard deviation (SD) 
and median (minimum to maximum), and as percentag-
es for categorical variables. The presence of  a normal 
distribution for each variable was tested by the Shapiro 
Wilks test. Continuous variables were compared be-
tween groups by independent samples t tests for nor-
mally distributed variables and the Mann–Whitney U 
test for non–normally distributed variables. Pearson 
chi-square, Yates corrected chi-squared, and Fisher's 
exact tests were performed for categorical variables. 
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Spearman’s rho correlation coefficient was used to 
identify the relationship between 25(OH)D and several 
continuous and numeric outcome variables: gestational 
age at serum collection, BMI, birth weight, Apgar score, 
gestational age at delivery. A logistic regression model 
was used to determine the factors associated with low 
levels of  vitamin D. All data was analyzed using SPSS 
(SPSS, Inc., Chicago, IL, USA) and p values <0.05 were 
considered statistically significant.
Results
A total of  286 women were invited to participate in 
this study. Fifty-seven of  them were excluded from 
the analysis. Reasons for exclusion were planned to be 
followed-up elsewhere (n=15), decline to participate 
(n=5), lost to follow up (n=27), insufficient serum 
available for analysis (n=7), miscarriage (n=2), and ter-
mination of  pregnancy because of  Down’s syndrome 
(n=1). After exclusion of  the women mentioned above, 
229 women were eligible for follow-up at the end of  
their pregnancy.
Characteristics of  the study population are shown in 
Table 1. The median serum 25(OH)D concentration 
was 13 ± 9,4 ng/mL at 11-14 weeks of  gestation, only 
4.4% of  the pregnancies had adequate serum 25(OH)D 
levels (>30 ng/mL). The prevalence of  severe, moder-
ate, and mild vitamin D deficiency was 45.9% (n=105), 
36.2%(n=83), and 13.5% (n=31), respectively.
Table 2 shows the baseline characteristics, and the ob-
stetric-neonatal outcomes of  the participants accord-
ing to vitamin D status. The subjects were divided into 
two groups using 25(OH)D < 10 ng/mL as a cut off  
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Table 1. Characteristics of the study population 
 
  
Data are shown as mean ± SD, median (minimum-maximum) or n (%). 
BMI, body mass index; BP, blood pressure; 25(OH)D, 25-hydroxyvitamin D 
Age (years) 29.49 ± 4.879 
Parity 
    Nulliparous, n (%) 




BMI (kg/m2) 25.3 ± 4.5 
Education, n (%) 
    0-5 years 
    6-8 years 





Smoking, n (%) 15 (6.6) 
Gestational age at serum collection (week) 13.2 (11-14) 
Season of blood sampling, n (%) 
    Winter (November-April) 




Mean systolic BP at trial entry (mmHg) 100 (80-165) 
Mean diastolic BP at trial entry (mmHg) 70 (50-100) 
Maternal multivitamin use, n (%) 
    Yes 




Consumption of dairy products, n (%) 
    Sufficient 




Dressing style, n (%) 
    Covered 




Exposure to sun, n (%) 
    Yes 




         38
limit to identify severe deficiency; 105 (46%) women 
had 25(OH)D <10 ng/mL (group 1), while 124 (54%) 
women had 25(OH)D ≥ 10 ng/mL (group 2). We also 
compared the groups and found no significant differ-
ences between the groups concerning maternal age, 
BMI values, parity, education level, smoking, systolic 
and diastolic blood pressures at the baseline study visit 
and gestational age at serum collection.
Table 2. Association of serum 25-hydroxyvitamin D [25(OH)D] with pregnancy outcomes 
 
 
  Serum 25 OH concentration ( ng/mL ) 
  < 10  ng/mL (n=105) = 10  ng/mL (n=124) p 
Age (years) a 28.85 ± 4.99 30.03 ± 4.73 0.067 
Parity b 
    Nulliparous, n (%) 










BMI (kg/m2) a 25.60 ± 4.8 25.03 ± 4.21 0.35 
Education, n (%) b 
    0-5 years 
    6-8 years 











Smoking, n (%) c 6 (5.7) 9 (7.4) 0.81 
Gestational age at serum collection (week)d 13.4 (11-14) 13.2 (11-14) 0.06 
Gestational age at delivery (week)  d 39 (34-41) 39 (24-41) 0.56 
Season of blood sampling, n (%) b 
    Winter (November-April) 









Mean systolic BP at trial entry (mmHg) d 100 (80-165) 100 (80-140) 0.84 
Mean diastolic BP at trial entry (mmHg)d 70 (50-95) 70 (50-100) 0.59 
Maternal multivitamin use, n (%) b 
     Yes 









Consumption of dairy products, n (%) b 
    Sufficient 










Dressing style, n (%) c 
    Covered 









Exposure to sun, n (%) b 
    Yes 









Mode of delivery, n (%) c 
    Vaginal delivery 









Gestational diabetes, n (%) c 10 (9.5) 10 (8.1) 0.87 
Hypertensive states, n (%) 
   Pre-eclampsia e 










Preterm birth, n (%) c 5 (4.8) 7 (5.6) 0.99 
Small for gestational age, n (%)  c 7 (6.7) 6 (4.8) 0.75 
Intrauterine fetal death, n (%) e 1 (1) 1 (1) 1 
Congenital malformation, n (%) c 2 (1.9) 1 (0.8) 0.88 
Birth weight (g) a 3245 ± 496 3272 ± 440 0.66 
Apgar score  d 
  1 min 










Infant gender (female), n (%) b 51 (51) 50 (44.6) 0.35 
Data are shown as mean ± SD, median (minimum-maximum) or n (%). at-test; b Pearson chi-squared test;  c Yates-
corrected chi squared test;  dMann–Whitney U test; e Fisher’s exact test 
BMI, body mass index; BP, blood pressure 
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Vitamin D status was found to be significantly higher 
in women who used multi-vitamins during pregnancy 
and who had higher consumption of  dairy products 
compared to women who did not use multi-vitamins 
and had lower consumption of  dairy products respec-
tively. Pregnant women whose blood samples were 
drawn in summer months had significantly higher levels 
of  25(OH)D than those examined in winter months. 
Women with covered dressing style had significant-
ly lower levels of  25(OH)D than that of  women who 
were dressed in uncovered style. Binary logistic regres-
sion analysis determined that covered dressing style, 
absence of  receiving multivitamin supplements, season 
of  blood sampling (November-April) were factors re-
lated to severe vitamin D deficiency, while other var-
iables such as BMI, parity, smoking, consumption of  
dairy products and sun exposure were not significantly 
related to 25(OH)D levels (Table 3).
Table 3. Logistic regression analysis of factors associated with serum 25(OH)D status 
 
Variables  ORa 95 % CI p-value 
Dressing style 
    Covered 










Maternal multivitamin use 
    No 










Season of blood sampling 
   Winter 











OR, odds ratio; CI, confidence interval; Ref, reference category. 
There were no differences in the frequency of  adverse 
obstetric and neonatal outcomes in women with 25(OH)
D concentrations <10 ng/mL compared to those with 
concentrations ≥10 ng/mL (Table 2).
The mode of  delivery was vaginal in 118 cases (51.5 %), 
and caesarean delivery in 111 cases (48.5%) of  which 52 
(30.7 %) had primary caesareans. The current analysis 
was limited to women who delivered vaginally and who 
delivered by primary caesarean. A significantly higher 
primary caesarean section rate was noted in women 
with 25(OH)D  concentration ≥10 ng/mL compared to 
those with 25(OH)D < 10 (67.3% vs 32.7%, p= 0.018).
There were no significant correlations between the 
25(OH)D levels and numerical outcome variables in-
cluding gestational age at delivery, birth weight and 
Apgar scores while there was  a weak  negative corre-
lation between 25(OH)D levels and gestational age at 
sampling (Spearman’s rho=−0.161, p=0.015). The cor-
relation analysis revealed that 25(OH)D levels at 11th 
week of  gestation was higher than those at 14th week 
of  gestation.
Discussion
The findings of  this study indicate that the higher prev-
elance of  severe vitamin D deficiency (45.8 %) in preg-
nant women is likely to be a result of  less exposure to 
sunlight due to their dress code and lack of  multivitamin 
usage. Higher rates of  severe vitamin D deficiency were 
previously reported in the literature from Turkey10,17. 
Those prior studies have shown that covered dress style 
may be an important factor affecting the prevalence of  
vitamin D deficiency in Muslim populations due to the 
religious and cultural reasons10,18. 
The prevalence of  low vitamin D levels was greater in 
cases which were sampled in winter, in women who had 
limited access to sunlight, those living in countries at 
higher latitudes and those with higher skin pigmenta-
tion16,18-20. In a study by Perez et al.,21 it was observed 
that only 35.9% of  pregnant women in the first trimes-
ter had adequate serum 25(OH)D levels (≥30 ng/mL) 
and non-Caucasian ethnicity, season at sampling (au-
tumn/winter) and nulliparity were found to be associat-
ed with 25(OH)D deficiency. The season at the time of  
serum sampling was also found to be important similar 
to previous studies which reported lower levels of  vita-
min D in the winter compared with summer season19,21. 
A study measuring serum 25(OH)D levels of  79 preg-
nant women in the third trimester in our country found 
considerably a high rate of  vitamin D deficiency in preg-
nant women during the winter season and it showed 
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also the relationship between multivitamin supplemen-
tation, good socioeconomic status and high levels of  
vitamin D17.
We found no significant association between low 
25(OH)D levels in the first trimester and adverse preg-
nancy outcomes which is in agreement with other re-
ports9,13,22.Bodnar et al.23 reported a five-fold increased 
risk of  pre-eclampsia in women with 25(OH)D <15 
ng/mL at <22 weeks of  pregnancy. On the contrary, 
Shand et al.24 evaluated vitamin D status (between 10 
and 20 week of  gestation) in a group of  women at high 
risk of  pre-eclampsia and found no association be-
tween vitamin D deficiency and risk of  pre-eclampsia. 
Wei et al.11 reported that 25(OH)D < 20 ng/mL at late 
mid-trimester (24-26 weeks of  gestation) but not early 
pregnancy (12-18 weeks of  gestation) was associated 
with increased risk of  pre-eclampsia. In contrast to our 
study, Parlea et al.25 noted a two- fold increased risk of  
GDM in women with 25(OH)D <29.4 at 15-18 weeks 
of  gestation.         
Similar to our findings, Thorp et al.26 reported no rela-
tion between recurrent preterm birth and low vitamin 
D levels (<20 ng/mL) in women at 16-22 week of  ges-
tation in a case control study of  women with prior pre-
term birth. Although we found no correlation between 
the first trimester serum 25(OH)D levels and the neo-
natal gestational age or weight, a recent study demon-
strated that first trimester 25(OH)D concentration of  
less than 12 ng/mL was associated with increased risk 
of  low birth weight and SGA infants18. A study in-
cluding 152 nulliparous women in Turkey showed that 
44.6% of  pregnant women have vitamin D deficiency 
and maternal vitamin D deficiency is associated with 
an increased risk of  SGA27.The variation in results be-
tween studies may also be explained by differences in 
cut-off  points used, population characteristics, sample 
size and methods to measure 25(OH)D22.
An interesting finding in our study was that women 
with higher levels of  vitamin D at first trimester had 
higher rate of  caesarean section than those with severe 
vitamin D  deficiency. It might be explained by the fact 
that women who deliver vaginally were more likely to 
have risk factors for vitamin D deficiency such as wear-
ing covered dress styles and less use of  multi-vitamins 
than women who had caesarean section. Furthermore, 
the current study was focused primarily on the first tri-
mester of  pregnancy and we cannot rule out the pos-
sibility that differences in 25(OH)D concentrations 
become apparent only in the third trimester. A recent 
study with a large size of  population revealed no asso-
ciation between the first trimester vitamin D status and 
the mode of  delivery28. Our findings are in contrast to 
those of  two other studies, Merewood et al.9 found al-
most four-fold increase in the rate of  primary caesarean 
section in women with 25(OH)D levels below 15 ng/ 
mL at the time of  the delivery, and Scholl et al.29 report-
ed increased risk for caesarean delivery for women with 
25(OH)D levels below 12 ng/ mL.
Strengths of  the current study include its prospective 
design and the use of  the gold-standard method for 
measuring 25(OH)D levels. The main limitation of  this 
study, on the other hand, is the small sample size and 
the small number of  women with adverse pregnancy 
outcome which limit making a definitive conclusion re-
garding the impact of  vitamin D status on adverse preg-
nancy outcomes. In addition, we could not completely 
evaluate the underlying factors such as sunscreen use, 
skin pigmentation, socioeconomic status and lifestyle 
behaviour contributing to vitamin D status. The other 
limitation of  our study is determining vitamin D status 
only in first trimester and the determination of  vitamin 
D status in third trimester would be benefical to indi-
cate the possible interaction of  vitamin D in pregnancy 
outcomes. In spite of  the limitations, this study adds 
to the few that report on serum 25(OH)D levels in the 
first trimester and its relation to pregnancy outcomes.
Conclusion
We propose that high prevalence of  severe vitamin D 
deficiency in the first-trimester among pregnant women 
can be related with dress code, use of  multi-vitamins 
and season at sampling. Low 25(OH)D levels may not 
be associated with increased risk of  adverse pregnan-
cy outcomes. Moreover, it is unanticipated that women 
with lower levels of  vitamin D are more likely to deliver 
vaginally. Yet, further research is required to determine 
the levels of  vitamin D in early pregnancy and the im-
pact of  low 25(OH)D concentrations on adverse preg-
nancy outcome.
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